ZIDOVUDINE Drug Patent Profile
✉ Email this page to a colleague
When do Zidovudine patents expire, and when can generic versions of Zidovudine launch?
Zidovudine is a drug marketed by Aurobindo Pharma Ltd, Cipla Ltd, Am Regent, Liaoning Chengda, Aurobindo, Aurobindo Pharma, Cipla, Hec Pharm, Hetero Labs Ltd Iii, Hikma, Mylan Labs Ltd, Mylan Pharms Inc, and Ranbaxy Labs Ltd. and is included in fifteen NDAs.
The generic ingredient in ZIDOVUDINE is zidovudine. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the zidovudine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zidovudine
A generic version of ZIDOVUDINE was approved as zidovudine by AUROBINDO on September 19th, 2005.
Summary for ZIDOVUDINE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 102 |
| Clinical Trials: | 524 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ZIDOVUDINE |
| DailyMed Link: | ZIDOVUDINE at DailyMed |
Recent Clinical Trials for ZIDOVUDINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Michelle Abou-Jaoude | Phase 1 |
| Inflammasome Therapeutics | Phase 1 |
| Johns Hopkins University | Phase 1/Phase 2 |
Pharmacology for ZIDOVUDINE
Medical Subject Heading (MeSH) Categories for ZIDOVUDINE
Anatomical Therapeutic Chemical (ATC) Classes for ZIDOVUDINE
US Patents and Regulatory Information for ZIDOVUDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | ZIDOVUDINE | zidovudine | CAPSULE;ORAL | 078128-001 | Mar 27, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Aurobindo | ZIDOVUDINE | zidovudine | TABLET;ORAL | 077267-001 | Sep 19, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Liaoning Chengda | ZIDOVUDINE | zidovudine | INJECTABLE;INJECTION | 204538-001 | Nov 26, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma | ZIDOVUDINE | zidovudine | TABLET;ORAL | 076844-001 | Sep 19, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Aurobindo Pharma | ZIDOVUDINE | zidovudine | TABLET;ORAL | 022294-001 | Jul 23, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Pharms Inc | ZIDOVUDINE | zidovudine | TABLET;ORAL | 078922-001 | Feb 14, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Cipla Ltd | ZIDOVUDINE | zidovudine | CAPSULE;ORAL | 078349-001 | May 23, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
